Nobuhiro Iwakura
Niigata University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nobuhiro Iwakura.
Journal of Clinical Microbiology | 2005
Yoko Takizawa; Ikue Taneike; Saori Nakagawa; Tomohiro Oishi; Yoshiyuki Nitahara; Nobuhiro Iwakura; Kyoko Ozaki; Misao Takano; Teruko Nakayama; Tatsuo Yamamoto
ABSTRACT Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) was collected from children with bullous impetigo in 2003 and 2004. One strain collected in 2003 was Panton-Valentine leucocidin (PVL) positive. In 2004, a multiple-drug-resistant PVL+ CA-MRSA strain was isolated from an athlete with a cutaneous abscess. These strains were analyzed by multilocus sequence typing, spa typing, agr typing, coagulase typing, staphylococcal cassette chromosome mec (SCCmec) typing, PCR assay for 30 virulence genes, drug susceptibility testing, pulsed-field gel electrophoresis, and for plasmids. The two Japanese PVL+ CA-MRSA strains belonged to the globally extant (“pandemic”) sequence type 30 (ST30) with SCCmec IV. A transmissible, multiple-drug resistance plasmid emerged in such ST30 strains. The PVL− CA-MRSA strains (“domestic” CA-MRSA) accumulated for bullous impetigo, exhibiting new genotypes. Hospital-acquired MRSA of ST91 (but not pandemic ST5) shared common features with the PVL− CA-MRSA strain.
Antimicrobial Agents and Chemotherapy | 2000
Nanako Tsutsui; Ikue Taneike; Tatsuki Ohara; Satoshi Goshi; Seiichi Kojio; Nobuhiro Iwakura; Hiroyuki Matsumaru; T. Noriko Wakisaka-Saito; Hui-Min Zhang; Tatsuo Yamamoto
ABSTRACT The motility of Helicobacter pylori was maximum at 37°C and at pH 6. A newly developed proton pump inhibitor, rabeprazole (RPZ), and its thioether derivative (RPZ-TH) markedly inhibited the motility of H. pylori. The concentrations of the drug necessary to inhibit 50% of the motility were 0.25, 16, 16, and >64 μg/ml for RPZ-TH, RPZ, lansoprazole, and omeprazole, respectively. No such inhibitory effects were observed with H2 blockers or anti-H. pylori agents. The motilities of Campylobacter jejuni and C. coli—but not those of Vibrio cholerae O1 and O139,Vibrio parahaemolyticus, Salmonella entericaserovar Typhimurium, and Proteus mirabilis—were also inhibited. Prolonged incubation with RPZ or RPZ-TH inhibited bacterial growth of only H. pylori, except for a turbid colony mutant. The results indicate that RPZ and RPZ-TH have a characteristic inhibitory effect against the motility of H. pylori(spiral-shaped bacteria), which is distinguished from that against bacterial growth.
Fems Microbiology Letters | 2003
Tatsuo Yamamoto; Seiichi Kojio; Ikue Taneike; Saori Nakagawa; Nobuhiro Iwakura; Noriko Wakisaka-Saito
Shiga toxin (Stx)-producing Escherichia coli (STEC), an important cause of hemolytic uremic syndrome, was completely killed by (60)Co irradiation at 1 x l0(3) gray (1 kGy) or higher. However, a low dose of irradiation (0.1-0.3 kGy) markedly induced Stx phage from STEC. Stx production was observed in parallel to the phage induction. Inactivation of Stx phage required a higher irradiation dose than that for bacterial killing. Regarding Stx, cytotoxicity was susceptible to irradiation, but cytokine induction activity was more resistant than Stx phage. The findings suggest that (1). although (60)Co irradiation is an effective means to kill the bacteria, it does induce Stx phage at a lower irradiation dose, with a risk of Stx phage transfer and emergence of new Stx-producing strains, and (2). irradiation differentially inactivates some activities of Stx.
Biochemical and Biophysical Research Communications | 2005
Saori Nakagawa; Ikue Taneike; Daigo Mimura; Nobuhiro Iwakura; Teruko Nakayama; Tomoko Emura; Maki Kitatsuji; Atsushi Fujimoto; Tatsuo Yamamoto
Biochemical and Biophysical Research Communications | 2006
Taketo Otsuka; Kohei Saito; Soshi Dohmae; Tomomi Takano; Wataru Higuchi; Yoko Takizawa; Takeshi Okubo; Nobuhiro Iwakura; Tatsuo Yamamoto
Fems Microbiology Letters | 2005
Akira Iwaya; Saori Nakagawa; Nobuhiro Iwakura; Ikue Taneike; Mizuki Kurihara; Tomoko Kuwano; Fumio Gondaira; Miyoko Endo; Katsuyoshi Hatakeyama; Tatsuo Yamamoto
Biochemical and Biophysical Research Communications | 2003
Saori Nakagawa; Seiichi Kojio; Ikue Taneike; Nobuhiro Iwakura; Yukiko Tamura; Koji Kushiya; Fumio Gondaira; Tatsuo Yamamoto
Journal of Infection and Chemotherapy | 2005
Koji Kushiya; Saori Nakagawa; Ikue Taneike; Nobuhiro Iwakura; Tatsuo Yamamoto; Hiroki Tsukada; Fumitake Gejyo; Ken'ichi Imanishi; Takehiko Uchiyama
Fems Immunology and Medical Microbiology | 2012
Akihito Nishiyama; Hirokazu Isobe; Yasuhisa Iwao; Tomomi Takano; Wei-Chun Hung; Ikue Taneike; Saori Nakagawa; Soshi Dohmae; Nobuhiro Iwakura; Tatsuo Yamamoto
Acta medica et biologica | 2002
Akira Iwata; Saori Nakagawa; Nobuhiro Iwakura